CORC  > 武汉大学
Rho-associated protein kinase inhibitor Y-27632 increases the sensitivity of lung adenocarcinoma A549 cells to matrine via the Rad51/ERCC1 signaling pathway
Liu, Xing; Xiao, Youzhang; Zhu, Jiaxing; Chen, Yuping; Wang, Jingjing; Peng, Yan; Jiang, Li; Hu, Yuhui; Bi, Yongyi
刊名INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
2016
卷号9期号:5
关键词Matrine Y-27632 lung cancer ERCC1 Rad51
ISSN号1940-5901
URL标识查看原文
收录类别SCIE
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4090107
专题武汉大学
推荐引用方式
GB/T 7714
Liu, Xing,Xiao, Youzhang,Zhu, Jiaxing,et al. Rho-associated protein kinase inhibitor Y-27632 increases the sensitivity of lung adenocarcinoma A549 cells to matrine via the Rad51/ERCC1 signaling pathway[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,2016,9(5).
APA Liu, Xing.,Xiao, Youzhang.,Zhu, Jiaxing.,Chen, Yuping.,Wang, Jingjing.,...&Bi, Yongyi.(2016).Rho-associated protein kinase inhibitor Y-27632 increases the sensitivity of lung adenocarcinoma A549 cells to matrine via the Rad51/ERCC1 signaling pathway.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,9(5).
MLA Liu, Xing,et al."Rho-associated protein kinase inhibitor Y-27632 increases the sensitivity of lung adenocarcinoma A549 cells to matrine via the Rad51/ERCC1 signaling pathway".INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 9.5(2016).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace